InsiderPulse
Dashboard

NUVL

Nuvalent, Inc.

Health CareRussell 2000

Nuvalent, Inc. insider trading

Nuvalent, Inc. files with the SEC as a Pharmaceutical Preparations company headquartered in Cambridge, MA. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.

From SEC filings

Recent NUVL insider transactions

4 insiders traded NUVL on the open market between Jun 08, 2026 and Jul 09, 2026 — 9 sales worth $14M, of which every one was pre-scheduled under a 10b5-1 plan.

Bought
—
Sold
$14M

9 of 9 on a 10b5-1 plan

Net
−$14M
Insiders
4

Open-market purchases (code P) and sales (code S) from Nuvalent, Inc.'s own SEC Form 4 filings. Grants and option exercises are excluded — they are compensation, not decisions. Share counts are derived from the reported value and price. Verify any figure against the original filing before acting on it; this is monitoring, not advice.

Filing history last read from EDGAR on Sep 23, 2026. The live dashboard shows new filings the moment they clear.

Every NUVL Form 4 on SEC.gov

SEC Form 4 data, Q3 2024 to Q2 2026

NUVL insider trading by quarter

Between Jul 01, 2024 and Jun 30, 2026, 11 insiders traded NUVL on the open market: 0 purchases and 385 sales worth $366.4M, 382 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 0 purchases and 218 sales ($114.5M), by 8 insiders.

QuarterBoughtSold
Q2 2026—−$17.3M43 sales · all on a plan
Q1 2026—−$20.3M75 sales · all on a plan
Q4 2025—−$64.2M68 sales · 67 on a plan
Q3 2025—−$12.7M32 sales · all on a plan
Q2 2025—−$9.2M20 sales · all on a plan
Q1 2025—−$12M41 sales · all on a plan
Q4 2024—−$218.6M33 sales · 31 on a plan
Q3 2024—−$12.1M73 sales · all on a plan
Largest sale
−$110M of NUVL by Hack Andrew A. F. (Director) on Dec 11, 2024.

Open-market transactions through Jun 30, 2026most recent first

  • Balcom Alexandra10b5-1

    Chief Financial Officer

    −$312.9K

    Jun 01, 2026

    3,133 sh · $99.86

  • Balcom Alexandra10b5-1

    Chief Financial Officer

    −$260.5K

    Jun 01, 2026

    2,588 sh · $100.65

  • Balcom Alexandra10b5-1

    Chief Financial Officer

    −$208.3K

    Jun 01, 2026

    2,170 sh · $95.99

  • Balcom Alexandra10b5-1

    Chief Financial Officer

    −$118.3K

    Jun 01, 2026

    1,200 sh · $98.57

  • Balcom Alexandra10b5-1

    Chief Financial Officer

    −$91.1K

    Jun 01, 2026

    960 sh · $94.87

  • Balcom Alexandra10b5-1

    Chief Financial Officer

    −$87.9K

    Jun 01, 2026

    900 sh · $97.68

  • Balcom Alexandra10b5-1

    Chief Financial Officer

    −$28.4K

    Jun 01, 2026

    279 sh · $101.79

  • Balcom Alexandra10b5-1

    Chief Financial Officer

    −$20.8K

    Jun 01, 2026

    200 sh · $103.84

  • Miller Deborah Ann10b5-1

    Chief Legal Officer

    −$182.4K

    May 28, 2026

    1,669 sh · $109.30

  • Miller Deborah Ann10b5-1

    Chief Legal Officer

    −$164.4K

    May 28, 2026

    1,530 sh · $107.45

  • Noci Darlene10b5-1

    Chief Development Officer

    −$164K

    May 28, 2026

    1,500 sh · $109.30

  • Noci Darlene10b5-1

    Chief Development Officer

    −$152.6K

    May 28, 2026

    1,422 sh · $107.33

  • Miller Deborah Ann10b5-1

    Chief Legal Officer

    −$149K

    May 28, 2026

    1,401 sh · $106.32

  • Noci Darlene10b5-1

    Chief Development Officer

    −$138.1K

    May 28, 2026

    1,300 sh · $106.26

  • Noci Darlene10b5-1

    Chief Development Officer

    −$127.2K

    May 28, 2026

    1,178 sh · $108.01

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

Nuvalent, Inc. company record

SEC industry classification
Pharmaceutical Preparations
Headquarters
Cambridge, MA
Incorporated in
DE
Listed on
Nasdaq
SEC Central Index Key
0001861560

Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.

After insiders bought NUVL

What the stock actually did in the 90 days following each open-market purchase

Don't check NUVL — let it ping you

Get told the moment an insider moves on NUVL

Pro watches Nuvalent, Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add NUVL to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.

Track NUVL on the live dashboardFilings on SEC.gov

The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.

How to read NUVL insider activity

Open-market purchase (code P)
An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
Grants and option exercises (codes A, M)
Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
Cluster buy
Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.

Other Health Care tickers

PCVXPTGXRVMDRYTMSMMTSNDXSRRKTGTXVERAVKTXXENEZLAB
This week on the tape: who actually chose to sellThe weekly split of scheduled 10b5-1 selling vs deliberate sales, with the deciders named.

Questions

Are NUVL insiders buying or selling?
Between Jun 08, 2026 and Jul 09, 2026, 4 Nuvalent, Inc. insiders made no open-market purchases and 9 sales worth $14M, a net sale of $14M. 9 of the sales were pre-scheduled under a Rule 10b5-1 plan.
How much NUVL stock have insiders bought and sold in the last two years?
Between Jul 01, 2024 and Jun 30, 2026, 11 Nuvalent, Inc. insiders made no open-market purchases and 385 sales worth $366.4M. 382 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: no purchases and 218 sales ($114.5M). The largest sale was Hack Andrew A. F. selling $110M on Dec 11, 2024.
What was the largest recent NUVL insider trade?
Porter James Richard (President and CEO · Director) sold $3.7M of NUVL stock on Jul 06, 2026 at about $123.72 a share, under a pre-scheduled 10b5-1 plan.
When did an insider last buy NUVL shares?
No open-market purchase by a Nuvalent, Inc. insider appears in the filings from Jun 08, 2026 to Jul 09, 2026 — every recorded open-market transaction in that period was a sale.
Where does NUVL insider trading data come from?
From the Form 4 filings Nuvalent, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

Get the free Insider Brief

Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.

No account needed. One-click unsubscribe.